Unity Biotechnology (UBX) Stock Analysis
NASDAQHealthcareBiotechnology
What Unity Biotechnology does
Unity Biotechnology, Inc. is a biotechnology firm specializing in the development of therapeutic solutions aimed at slowing, halting, or even reversing age-associated diseases. Leading its pipeline, the drug candidate UBX1325 is currently undergoing Phase II clinical trials to treat age-related vision disorders, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. Additionally, the company is advancing UBX1967 for various ophthalmologic conditions, while UBX2050, a human anti-Tie2 agonist monoclonal antibody, also targets age-related eye diseases. Furthermore, UBX2089, an a-Klotho hormone drug candidate, is in development for numerous neurological indications. Established in 2009 as Forge, Inc., the company adopted the name Unity Biotechnology, Inc. in January 2015 and is headquartered in South San Francisco, California.
Key metrics
ETFs linked to UBX
Broad-market and Healthcare sector ETFs an investor holding Unity Biotechnology is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how UBX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze UBX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Unity Biotechnology?
- Unity Biotechnology trades under the ticker UBX on NASDAQ.
- Which exchange is UBX listed on?
- UBX is listed on NASDAQ.
- What sector does Unity Biotechnology operate in?
- Unity Biotechnology is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze UBX in a portfolio?
- PortView shows UBX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.